Johnson & Johnson (JNJ) News Today → Gold Set to EXPLODE! (From Gold Safe Exchange) (Ad) Free JNJ Stock Alerts $149.70 -3.80 (-2.48%) (As of 05:32 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 23 at 5:58 PM | seekingalpha.comJohnson & Johnson: Vital Signs Decent, A Compelling Value CaseMay 23 at 3:47 PM | marketbeat.comJohnson & Johnson (NYSE:JNJ) Shares Down 1.1% Johnson & Johnson (NYSE:JNJ) Trading Down 1.1%May 23 at 11:32 AM | marketbeat.comCentral Valley Advisors LLC Makes New Investment in Johnson & Johnson (NYSE:JNJ)Central Valley Advisors LLC acquired a new stake in Johnson & Johnson (NYSE:JNJ - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 5,730 shares of the company's stock, valuedMay 23 at 4:30 AM | americanbankingnews.comJohnson & Johnson (NYSE:JNJ) Receives "Outperform" Rating from Royal Bank of CanadaMay 22 at 11:37 PM | marketbeat.comV Square Quantitative Management LLC Purchases 9,807 Shares of Johnson & Johnson (NYSE:JNJ)V Square Quantitative Management LLC increased its stake in shares of Johnson & Johnson (NYSE:JNJ - Free Report) by 29.6% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 42,924 shares of the company's stMay 22 at 3:12 PM | reuters.comCancer victims sue Johnson & Johnson over 'fraudulent' bankruptciesMay 22 at 2:16 PM | marketbeat.comJohnson & Johnson (NYSE:JNJ) Trading 1.2% Higher Johnson & Johnson (NYSE:JNJ) Stock Price Up 1.2%May 22 at 12:05 PM | businesswire.comProposed Class Action Filed by Six Law Firms Alleging Series of Fraudulent Transfers by Johnson & Johnson in Talc LitigationMay 22 at 10:17 AM | marketbeat.comJohnson & Johnson (NYSE:JNJ) Rating Reiterated by Royal Bank of CanadaRoyal Bank of Canada reaffirmed an "outperform" rating and issued a $175.00 target price on shares of Johnson & Johnson in a research note on Wednesday.May 22 at 9:48 AM | investorplace.com7 Safe-Haven Stocks to Weather Any StormMay 21 at 11:19 PM | markets.businessinsider.comBuy Recommendation for Johnson & Johnson on Promising Tremfya Clinical Data and Market Expansion PotentialMay 21 at 4:42 PM | marketbeat.comJohnson & Johnson (NYSE:JNJ) Stock Price Down 0.2%Johnson & Johnson (NYSE:JNJ) Shares Down 0.2%May 21 at 1:41 PM | investorplace.com7 Dividend Kings to Buy for Royal Passive Income: May EditionMay 21 at 10:57 AM | fool.comWant $1,000 in Dividend Income? Here's How Much You'd Have to Invest in Johnson & Johnson StockMay 21 at 7:56 AM | marketbeat.comCornerstone Advisors LLC Sells 7,098 Shares of Johnson & Johnson (NYSE:JNJ)Cornerstone Advisors LLC trimmed its holdings in shares of Johnson & Johnson (NYSE:JNJ - Free Report) by 5.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 115,402 shares of the company's stock after selling 7,098 sharesMay 20 at 3:38 PM | markets.businessinsider.comCiti Keeps Their Buy Rating on Johnson & Johnson (JNJ)May 20 at 3:30 PM | marketbeat.comJohnson & Johnson (NYSE:JNJ) Trading Down 0.5%Johnson & Johnson (NYSE:JNJ) Trading Down 0.5%May 20 at 1:22 PM | investorplace.comThe AI Stock Underdogs: 7 Underappreciated Companies Poised for GreatnessMay 20 at 7:52 AM | marketbeat.comSecurian Asset Management Inc. Sells 20,342 Shares of Johnson & Johnson (NYSE:JNJ)Securian Asset Management Inc. lowered its stake in Johnson & Johnson (NYSE:JNJ - Free Report) by 11.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 152,461 shares of the company's stock after selling 20,342 sMay 19, 2024 | marketbeat.comEquity Investment Corp Sells 17,727 Shares of Johnson & Johnson (NYSE:JNJ)Equity Investment Corp trimmed its stake in Johnson & Johnson (NYSE:JNJ - Free Report) by 17.4% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 83,924 shares of the company's stock after selling 17,727 sharMay 19, 2024 | americanbankingnews.comJohnson & Johnson (NYSE:JNJ) Earns Outperform Rating from Royal Bank of CanadaMay 19, 2024 | americanbankingnews.comJohnson & Johnson (NYSE:JNJ) Trading Down 0.1%May 18, 2024 | msn.comJohnson & Johnson-backed Rapport Therapeutics files for $100M IPOMay 18, 2024 | marketbeat.comJohnson & Johnson (NYSE:JNJ) is Addison Capital Co's 3rd Largest PositionAddison Capital Co raised its position in Johnson & Johnson (NYSE:JNJ - Free Report) by 12.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 46,205 shares of the company's stock after acquiring an additional 5,175 shMay 17, 2024 | finance.yahoo.comJohnson & Johnson Insiders Sell US$6.8m Of Stock, Possibly Signalling CautionMay 17, 2024 | reuters.comJ&J-backed startup Rapport files for US IPOMay 17, 2024 | marketbeat.comJohnson & Johnson (NYSE:JNJ) Stock Price Down 0.1%Johnson & Johnson (NYSE:JNJ) Shares Down 0.1%May 17, 2024 | marketbeat.comCCLA Investment Management Sells 15,969 Shares of Johnson & Johnson (NYSE:JNJ)CCLA Investment Management lowered its holdings in shares of Johnson & Johnson (NYSE:JNJ - Free Report) by 84.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,968 shares of the company's stock after sellMay 17, 2024 | investorplace.com7 Value Stocks to Buy and Hold for a Decade of DominanceMay 17, 2024 | investorplace.com3 Cheap Healthcare Stocks to Buy Now: May 2024May 16, 2024 | marketbeat.comShort Interest in Johnson & Johnson (NYSE:JNJ) Expands By 6.7%Johnson & Johnson (NYSE:JNJ - Get Free Report) was the recipient of a significant increase in short interest during the month of April. As of April 30th, there was short interest totalling 17,670,000 shares, an increase of 6.7% from the April 15th total of 16,560,000 shares. Approximately 0.7% of the shares of the company are sold short. Based on an average daily trading volume, of 7,630,000 shares, the days-to-cover ratio is presently 2.3 days.May 16, 2024 | msn.comRare but deadly blood clots tied to Johnson & Johnson and AstraZeneca Covid-19 vaccines: scientists report to journalMay 16, 2024 | markets.businessinsider.comJohnson & Johnson To Acquire Proteologix For $850 MlnMay 16, 2024 | finance.yahoo.comJohnson & Johnson to Buy Proteologix For $850 Million in CashMay 16, 2024 | finance.yahoo.comJohnson & Johnson To Acquire Early-Stage Eczema Treatment Developer Proteologix For $850MMay 16, 2024 | marketbeat.comJohnson & Johnson (NYSE:JNJ) Shares Up 0.3%Johnson & Johnson (NYSE:JNJ) Shares Up 0.3%May 16, 2024 | marketbeat.comHikari Tsushin Inc. Reduces Holdings in Johnson & Johnson (NYSE:JNJ)Hikari Tsushin Inc. cut its position in shares of Johnson & Johnson (NYSE:JNJ - Free Report) by 4.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 136,468 shares of the company's stoMay 16, 2024 | finance.yahoo.comJohnson & Johnson to Acquire Proteologix, Inc. to Lead in Atopic Dermatitis TreatmentMay 16, 2024 | reuters.comJohnson & Johnson to acquire Proteologix for $850 millionMay 16, 2024 | businesswire.comJohnson & Johnson to Acquire Proteologix, Inc. to Lead in Atopic Dermatitis TreatmentMay 16, 2024 | investorplace.comConsumer Staples Standouts: 3 Defensive Gems to Safeguard Your PortfolioMay 15, 2024 | marketbeat.comJohnson & Johnson (NYSE:JNJ) Shares Up 0.1%Johnson & Johnson (NYSE:JNJ) Shares Up 0.1%May 15, 2024 | seekingalpha.comJohnson & Johnson (JNJ) RBC Capital Markets Global Healthcare Conference (Transcript)May 15, 2024 | marketbeat.comIeq Capital LLC Cuts Position in Johnson & Johnson (NYSE:JNJ)Ieq Capital LLC decreased its stake in Johnson & Johnson (NYSE:JNJ - Free Report) by 24.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 107,201 shares of the company's stock after selling 34,529 shares during the periMay 14, 2024 | seekingalpha.comJohnson & Johnson (JNJ) BofA Securities Health Care Conference (Transcript)May 14, 2024 | seekingalpha.comJohnson & Johnson (JNJ) Management Presents at BofA Securities Health Care Conference (Transcript)May 14, 2024 | finance.yahoo.comIs Ardagh Metal Packaging SA (NYSE:AMBP) the Best High-Dividend Penny Stock to Buy Now?May 14, 2024 | marketbeat.comJohnson & Johnson (NYSE:JNJ) Shares Up 0.2%Johnson & Johnson (NYSE:JNJ) Stock Price Up 0.2%May 14, 2024 | marketbeat.comSeizert Capital Partners LLC Lowers Position in Johnson & Johnson (NYSE:JNJ)Seizert Capital Partners LLC lessened its position in Johnson & Johnson (NYSE:JNJ - Free Report) by 4.4% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 250,330 shares of the company's stock after selling 11,632May 13, 2024 | marketbeat.comJohnson & Johnson (NYSE:JNJ) Stock Price Up 0.6%Johnson & Johnson (NYSE:JNJ) Trading Up 0.6% Get Johnson & Johnson News Delivered to You Automatically Sign up to receive the latest news and ratings for JNJ and its competitors with MarketBeat's FREE daily newsletter. Email Address Write this ticker symbol down… (Ad)A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made millionaire Tim Bohen is giving you an inside look at the megatrend that’s going to change everything. Discover the #1 company leading this revolution JNJ Media Mentions By Week JNJ Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. JNJ News Sentiment▼0.640.44▲Average Medical News Sentiment JNJ News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. JNJ Articles This Week▼3729▲JNJ Articles Average Week Get Johnson & Johnson News Delivered to You Automatically Sign up to receive the latest news and ratings for JNJ and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Merck & Co., Inc. News Today AbbVie News Today Pfizer News Today Eli Lilly and Company News Today AstraZeneca News Today Novartis News Today Abbott Laboratories News Today Novo Nordisk A/S News Today Sanofi News Today Vertex Pharmaceuticals News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:JNJ) was last updated on 5/23/2024 by MarketBeat.com Staff From Our Partners[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaProtect Your Bank Account Before It’s Too LateWeiss RatingsMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceWrite this ticker symbol down…StocksToTrade**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsThis could mean the end of the U.S dollar…Colonial MetalsThis military-backed stock “owns” AI marketPorter & CompanyBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Johnson & Johnson Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
